pFLAG-YAP1 Citations (11)
Originally described in: A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.Bao Y, Nakagawa K, Yang Z, Ikeda M, Withanage K, Ishigami-Yuasa M, Okuno Y, Hata S, Nishina H, Hata Y J Biochem. 2011 Aug;150(2):199-208. doi: 10.1093/jb/mvr063. Epub 2011 May 17. PubMed Journal
Articles Citing pFLAG-YAP1
| Articles |
|---|
| G9a inhibition induced PKM2 regulates autophagic responses. Ahmad F, Dixit D, Joshi SD, Sen E. Int J Biochem Cell Biol. 2016 Sep;78:87-95. doi: 10.1016/j.biocel.2016.07.009. Epub 2016 Jul 11. PubMed |
| Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets. Crook ZR, Sevilla GP, Friend D, Brusniak MY, Bandaranayake AD, Clarke M, Gewe M, Mhyre AJ, Baker D, Strong RK, Bradley P, Olson JM. Nat Commun. 2017 Dec 21;8(1):2244. doi: 10.1038/s41467-017-02098-8. PubMed |
| MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Cui J, Zhou Z, Yang H, Jiao F, Li N, Gao Y, Wang L, Chen J, Quan M. Mol Cancer Res. 2019 Jun;17(6):1316-1325. doi: 10.1158/1541-7786.MCR-18-0910. Epub 2019 Feb 22. PubMed |
| A New Regulatory Mechanism Between P53 And YAP Crosstalk By SIRT1 Mediated Deacetylation To Regulate Cell Cycle And Apoptosis In A549 Cell Lines. Yuan F, Wang J, Li R, Zhao X, Zhang Y, Liu B, Lei Y, Hu Y. Cancer Manag Res. 2019 Sep 23;11:8619-8633. doi: 10.2147/CMAR.S214826. eCollection 2019. PubMed |
| Angiomotin regulates budding and spread of Ebola virus. Han Z, Ruthel G, Dash S, Berry CT, Freedman BD, Harty RN, Shtanko O. J Biol Chem. 2020 Jun 19;295(25):8596-8601. doi: 10.1074/jbc.AC120.013171. Epub 2020 May 7. PubMed |
| beta-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling. Yang D, Xu X, Wang X, Feng W, Shen X, Zhang J, Liu H, Xie C, Wu Q, Miao X, Guo Y, Cai H, Wu L, Zhou S, Yao X, Wang Y, Xie T, Huang Z. Am J Cancer Res. 2021 Feb 1;11(2):370-388. eCollection 2021. PubMed |
| Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Yan H, Yu CC, Fine SA, Youssof AL, Yang YR, Yan J, Karg DC, Cheung EC, Friedman RA, Ying H, Chen EI, Luo J, Miao Y, Qiu W, Su GH. Oncogene. 2021 Dec;40(50):6759-6771. doi: 10.1038/s41388-021-02040-9. Epub 2021 Oct 18. PubMed |
| YAP/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis. Li H, Wu BK, Kanchwala M, Cai J, Wang L, Xing C, Zheng Y, Pan D. Nat Cell Biol. 2022 Mar;24(3):373-383. doi: 10.1038/s41556-022-00848-5. Epub 2022 Feb 17. PubMed |
| WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. Wang K, Ma F, Arai S, Wang Y, Varkaris A, Poluben L, Voznesensky O, Xie F, Zhang X, Yuan X, Balk SP. Cancer Res. 2023 Apr 4;83(7):1016-1030. doi: 10.1158/0008-5472.CAN-22-3003. PubMed |
| NEK1-Mediated Phosphorylation of YAP1 Is Key to Prostate Cancer Progression. Ghosh I, Khalil MI, Mirza R, King J, Olatunde D, De Benedetti A. Biomedicines. 2023 Feb 28;11(3):734. doi: 10.3390/biomedicines11030734. PubMed |
| ATXN3 deubiquitinates YAP1 to promote tumor growth. Wang S, Liu K, Han X, Cheng Y, Zhao E, Brat DJ, Sun Z, Fang D. Am J Cancer Res. 2023 Sep 15;13(9):4222-4234. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.